Withanoside IV is known for its neuroprotective properties and is studied for its potential in supporting cognitive health. It has shown promise in promoting nerve cell regeneration and enhancing synaptic plasticity, making it a compound of interest in neurodegenerative research, particularly for conditions like Alzheimer's and Parkinson’s diseases. It may also help reduce neuroinflammation and oxidative stress in brain tissues. Additionally, Withanoside IV has been investigated for its role in improving memory and learning functions in preclinical models. Its ability to modulate key signaling pathways involved in neuronal survival further supports its therapeutic exploration in brain health and recovery from neural injury.